A Signal Starts at the Surface

Most peptide hormones are too large and too water-loving to slip through the fatty membrane that wraps a cell. They do not need to. They bind a receptor that sits in the membrane and let that protein pass the message inward.

The receptor family that does most of the work

The biggest group is the G protein-coupled receptors, usually shortened to GPCRs. Humans have roughly 800 of them, and a large share of modern medicines act on this family. A GPCR is one long protein that weaves through the membrane seven times. The outer end forms a pocket that fits a particular messenger. The inner end meets a helper called a G protein.

When the right peptide docks, the receptor changes shape. That small movement is the signal. On the inside, the G protein is released and goes off to start a chain of events (the next stop on this line covers that chain).

Fit is a spectrum, not a switch

A messenger can fit a pocket tightly or loosely, and it can switch the receptor fully on or only partly. Two words describe this:

• Affinity: how strongly the peptide holds on to the receptor.
• Efficacy: how much response it produces once bound.

A peptide can hold tight and still do little, and a loosely bound one can trigger a strong response. Both numbers matter when comparing two compounds that hit the same receptor.

Why this matters when reading claims

A statement such as "this peptide activates receptor X" is only the start of the story. It does not say how strongly, in which tissues the receptor is present, or what the cell does next. Receptors are spread unevenly through the body, so the same messenger can do different jobs in different places.

A receptor is a doorbell, not a door. What happens next depends on who is home and how long the bell rings.

Everything else on this map builds on that picture: a message arrives at the surface, is converted into a signal inside, and then fades.